|
3 Companies |
|
2 Products |
|
2 Products |
|
2 Mechanisms of Action |
|
0 Trials |
|
45 News |
|
- | amphotericin b liposome / Generic mfg.
Trial completion, Enrollment change, Combination therapy, Monotherapy: Efficacy Trial of Ambisome Given Alone and Ambisome Given in Combination With Miltefosine for the Treatment of VL HIV Positive Ethiopian Patients. (clinicaltrials.gov) - Apr 20, 2019
P3, N=59, Completed, Sponsor: Drugs for Neglected Diseases
Active, not recruiting --> Completed | N=132 --> 59
- Trial completion: Rapid Diagnostic Tests and Clinical/Laboratory Predictors of Tropical Diseases In Patients With Persistent Fever in Cambodia, Nepal, Democratic Republic of the Congo and Sudan (NIDIAG-Fever) (clinicaltrials.gov) - Oct 27, 2016
P=N/A, N=1927, Completed, Sponsor: University Hospital, Geneva
Active, not recruiting --> Completed | N=132 --> 59 Active, not recruiting --> Completed
- amphotericin b liposome / Generic mfg.
Trial primary completion date, Combination therapy, Monotherapy: Efficacy Trial of Ambisome Given Alone and Ambisome Given in Combination With Miltefosine for the Treatment of VL HIV Positive Ethiopian Patients. (clinicaltrials.gov) - Mar 21, 2016
P3, N=132, Active, not recruiting, Sponsor: Drugs for Neglected Diseases
Active, not recruiting --> Completed Trial primary completion date: Jan 2016 --> Aug 2016
- Trial completion: Phase 1 LEISH-F3 + SLA-SE Vaccine Trial in Healthy Adult Volunteers (clinicaltrials.gov) - Feb 23, 2016
P1, N=39, Completed, Sponsor: IDRI
Trial primary completion date: Jan 2016 --> Aug 2016 Active, not recruiting --> Completed
- | Trial completion: Prophylaxis of Visceral Leishmaniasis Relapses in HIV Co-infected Patients With Pentamidine: a Cohort Study (clinicaltrials.gov) - Feb 5, 2016
P3, N=72, Completed, Sponsor: Institute of Tropical Medicine, Belgium
Active, not recruiting --> Completed Active, not recruiting --> Completed
- amphotericin b liposome / Generic mfg.
Enrollment change, Trial primary completion date: Open-Label, Sequential Step, Safety and Efficacy Study to Determine the Optimal Single Dose of Ambisome for Patients With VL (clinicaltrials.gov) - Jan 21, 2016
P2, N=124, Terminated, Sponsor: Drugs for Neglected Diseases
Active, not recruiting --> Completed N=240 --> 124 | Trial primary completion date: Jun 2011 --> Sep 2010
- | amphotericin b liposome / Generic mfg.
Trial completion, Trial primary completion date: Phase III, Study of Three Short Course Combo (Ambisome (clinicaltrials.gov) - Jan 21, 2016
P3, N=602, Completed, Sponsor: Drugs for Neglected Diseases
N=240 --> 124 | Trial primary completion date: Jun 2011 --> Sep 2010 Recruiting --> Completed | Trial primary completion date: Dec 2011 --> Mar 2014
- Trial completion: Bihar Evaluation of Social Franchising and Telemedicine (clinicaltrials.gov) - Dec 16, 2015
P=N/A, N=106380, Completed, Sponsor: Duke University
Recruiting --> Completed | Trial primary completion date: Dec 2011 --> Mar 2014 Active, not recruiting --> Completed
- Trial primary completion date: Prophylaxis of Visceral Leishmaniasis Relapses in HIV Co-infected Patients With Pentamidine: a Cohort Study (clinicaltrials.gov) - Sep 24, 2015
P3, N=72, Active, not recruiting, Sponsor: Institute of Tropical Medicine, Belgium
Active, not recruiting --> Completed Trial primary completion date: Aug 2015 --> Dec 2015
- Fexinidazole Winthrop (fexinidazole) / Sanofi
Enrollment change, Trial termination: Trial to Determine Efficacy of Fexinidazole in Visceral Leihmaniasis Patients in Sudan (clinicaltrials.gov) - Sep 18, 2015
P2, N=14, Terminated, Sponsor: Drugs for Neglected Diseases
Trial primary completion date: Aug 2015 --> Dec 2015 N=66 --> 14 | Recruiting --> Terminated; Lack of efficacy
- | amphotericin b liposome / Generic mfg.
Enrollment closed, Combination therapy, Monotherapy: Efficacy Trial of Ambisome Given Alone and Ambisome Given in Combination With Miltefosine for the Treatment of VL HIV Positive Ethiopian Patients. (clinicaltrials.gov) - Sep 18, 2015
P3, N=132, Active, not recruiting, Sponsor: Drugs for Neglected Diseases
N=66 --> 14 | Recruiting --> Terminated; Lack of efficacy Recruiting --> Active, not recruiting
- Trial primary completion date: Phase 1 LEISH-F3 + SLA-SE Vaccine Trial in Healthy Adult Volunteers (clinicaltrials.gov) - Aug 25, 2015
P1, N=39, Active, not recruiting, Sponsor: IDRI
Recruiting --> Active, not recruiting Trial primary completion date: Jun 2015 --> Dec 2015
- || Trial primary completion date: Bihar Evaluation of Social Franchising and Telemedicine (clinicaltrials.gov) - Jun 16, 2015
P=N/A, N=106380, Active, not recruiting, Sponsor: Duke University
Trial primary completion date: Jun 2015 --> Dec 2015 Trial primary completion date: Apr 2015 --> Dec 2014
- Enrollment closed: Rapid Diagnostic Tests and Clinical/Laboratory Predictors of Tropical Diseases In Patients With Persistent Fever in Cambodia, Nepal, Democratic Republic of the Congo and Sudan (NIDIAG-Fever) (clinicaltrials.gov) - Apr 14, 2015
P=N/A, N=1927, Active, not recruiting, Sponsor: University Hospital, Geneva
Trial primary completion date: Apr 2015 --> Dec 2014 Recruiting --> Active, not recruiting
- || Enrollment closed: Bihar Evaluation of Social Franchising and Telemedicine (clinicaltrials.gov) - Feb 27, 2015
P=N/A, N=106380, Active, not recruiting, Sponsor: Duke University
Recruiting --> Active, not recruiting Enrolling by invitation --> Active, not recruiting
- | Trial completion: Replacement of Insecticides to Control Visceral Leishmaniasis (VL) (clinicaltrials.gov) - Feb 19, 2015
P3, N=3600, Completed, Sponsor: International Centre for Diarrhoeal Disease Research, Bangladesh
Enrolling by invitation --> Active, not recruiting Recruiting --> Completed
- Trial primary completion date: Prophylaxis of Visceral Leishmaniasis Relapses in HIV Co-infected Patients With Pentamidine: a Cohort Study (clinicaltrials.gov) - Jan 22, 2015
P3, N=72, Active, not recruiting, Sponsor: Institute of Tropical Medicine, Belgium
Recruiting --> Completed Trial primary completion date: Aug 2014 --> Aug 2015
- Enrollment closed: Phase 1 LEISH-F3 + SLA-SE Vaccine Trial in Healthy Adult Volunteers (clinicaltrials.gov) - Nov 24, 2014
P1, N=39, Active, not recruiting, Sponsor: Infectious Disease Research Institute
Trial primary completion date: Aug 2014 --> Aug 2015 Recruiting --> Active, not recruiting
- Trial completion, Trial primary completion date, IO biomarker: A Study to Explore Association of Treatment Regimens for Visceral Leishmaniasis, Host Immunological, Genetical and Nutrition Factors With Post-kala-azar Dermal Leishmaniasis (PKDL) (clinicaltrials.gov) - Nov 5, 2014
P4, N=36, Completed, Sponsor: International Centre for Diarrhoeal Disease Research, Bangladesh
Recruiting --> Active, not recruiting Active, not recruiting --> Completed | Trial primary completion date: Dec 2013 --> Sep 2014
- | amphotericin b liposome / Generic mfg.
Enrollment open, Combination therapy, Monotherapy: Efficacy Trial of Ambisome Given Alone and Ambisome Given in Combination With Miltefosine for the Treatment of VL HIV Positive Ethiopian Patients. (clinicaltrials.gov) - Sep 29, 2014
P3, N=132, Recruiting, Sponsor: Drugs for Neglected Diseases
Active, not recruiting --> Completed | Trial primary completion date: Dec 2013 --> Sep 2014 Not yet recruiting --> Recruiting
- |||| Lenocta (sodium stibogluconate) / VioQuest
Trial completion: Clinical Trial to Assess the Safety and Efficacy of Sodium Stibogluconate (SSG) and AmBisome (clinicaltrials.gov) - Sep 29, 2014
P2, N=183, Completed, Sponsor: Drugs for Neglected Diseases
Not yet recruiting --> Recruiting Recruiting --> Completed
- Trial primary completion date: Replacement of Insecticides to Control Visceral Leishmaniasis (VL) (clinicaltrials.gov) - Jul 12, 2014
P3, N=3600, Recruiting, Sponsor: International Centre for Diarrhoeal Disease Research, Bangladesh
Recruiting --> Completed Trial primary completion date: Dec 2013 --> Dec 2014
- | amphotericin b liposome / Generic mfg.
Trial initiation date, Trial primary completion date, Combination therapy, Monotherapy: Efficacy Trial of Ambisome Given Alone and Ambisome Given in Combination With Miltefosine for the Treatment of VL HIV Positive Ethiopian Patients. (clinicaltrials.gov) - Jul 12, 2014
P3, N=132, Not yet recruiting, Sponsor: Drugs for Neglected Diseases
Trial primary completion date: Dec 2013 --> Dec 2014 Initiation date: Dec 2013 --> Jul 2014 | Trial primary completion date: Jun 2015 --> Jan 2016
- amphotericin b liposome / Generic mfg.
Trial primary completion date: LVBrasil: Efficacy and Safety Study of Drugs for Treatment of Visceral Leishmaniasis in Brazil (clinicaltrials.gov) - Jun 3, 2014
P4, N=380, Terminated, Sponsor: University of Brasilia
Initiation date: Dec 2013 --> Jul 2014 | Trial primary completion date: Jun 2015 --> Jan 2016 Trial primary completion date: Jun 2014 --> Nov 2014
- amphotericin b liposome / Generic mfg.
Trial termination: LVBrasil: Efficacy and Safety Study of Drugs for Treatment of Visceral Leishmaniasis in Brazil (clinicaltrials.gov) - Jun 3, 2014
P4, N=380, Terminated, Sponsor: University of Brasilia
Trial primary completion date: Jun 2014 --> Nov 2014 Recruiting --> Terminated; DSMB recommendation based on programmed interim analysis.
- Trial primary completion date: Rapid Diagnostic Tests and Clinical/Laboratory Predictors of Tropical Diseases In Patients With Persistent Fever in Cambodia, Nepal, Democratic Republic of the Congo and Sudan (NIDIAG-Fever) (clinicaltrials.gov) - May 12, 2014
P=N/A, N=2170, Recruiting, Sponsor: University Hospital, Geneva
Recruiting --> Terminated; DSMB recommendation based on programmed interim analysis. Trial primary completion date: Feb 2014 --> Dec 2014
- Trial completion date: Rapid Diagnostic Tests and Clinical/Laboratory Predictors of Tropical Diseases In Patients With Persistent Fever in Cambodia, Nepal, Democratic Republic of the Congo and Sudan (NIDIAG-Fever) (clinicaltrials.gov) - May 12, 2014
P=N/A, N=2170, Recruiting, Sponsor: University Hospital, Geneva
Trial primary completion date: Feb 2014 --> Dec 2014 Trial completion date: May 2014 --> Dec 2014
- Enrollment open: Phase 1 LEISH-F3 + SLA-SE Vaccine Trial in Healthy Adult Volunteers (clinicaltrials.gov) - Apr 1, 2014
P1, N=36, Recruiting, Sponsor: Infectious Disease Research Institute
Trial completion date: May 2014 --> Dec 2014 Not yet recruiting --> Recruiting
- New P1 trial: Phase 1 LEISH-F3 + SLA-SE Vaccine Trial in Healthy Adult Volunteers (clinicaltrials.gov) - Feb 24, 2014
P1, N=36, Recruiting, Sponsor: Infectious Disease Research Institute
- || amphotericin b liposome / Generic mfg.
New P3 trial, Combination therapy, Monotherapy: Efficacy Trial of Ambisome Given Alone and Ambisome Given in Combination With Miltefosine for the Treatment of VL HIV Positive Ethiopian Patients. (clinicaltrials.gov) - Dec 12, 2013
P3, N=132, Not yet recruiting, Sponsor: Drugs for Neglected Diseases
- Fexinidazole Winthrop (fexinidazole) / Sanofi
Enrollment open: Trial to Determine Efficacy of Fexinidazole in Visceral Leihmaniasis Patients in Sudan (clinicaltrials.gov) - Nov 11, 2013
P2, N=66, Recruiting, Sponsor: Drugs for Neglected Diseases
Not yet recruiting --> Recruiting Not yet recruiting --> Recruiting
- | Fexinidazole Winthrop (fexinidazole) / Sanofi
New P2 trial: Trial to Determine Efficacy of Fexinidazole in Visceral Leihmaniasis Patients in Sudan (clinicaltrials.gov) - Nov 6, 2013
P2, N=66, Recruiting, Sponsor: Drugs for Neglected Diseases
- New P4 trial, IO biomarker: A Study to Explore Association of Treatment Regimens for Visceral Leishmaniasis, Host Immunological, Genetical and Nutrition Factors With Post-kala-azar Dermal Leishmaniasis (PKDL) (clinicaltrials.gov) - Oct 31, 2013
P4, N=36, Active, not recruiting, Sponsor: International Centre for Diarrhoeal Disease Research, Bangladesh
- | Enrollment closed: Prophylaxis of Visceral Leishmaniasis Relapses in HIV Co-infected Patients With Pentamidine: a Cohort Study (clinicaltrials.gov) - Oct 27, 2013
P3, N=72, Active, not recruiting, Sponsor: Institute of Tropical Medicine, Belgium
Not yet recruiting --> Recruiting Recruiting --> Active, not recruiting
- amphotericin b liposome / Generic mfg.
Trial withdrawal, Combination therapy: SCH708980 With and Without AmBisome for Visceral Leishmaniasis (clinicaltrials.gov) - Aug 25, 2013
P1/2, N=0, Withdrawn, Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting --> Active, not recruiting Not yet recruiting --> Withdrawn
- amphotericin b liposome / Generic mfg.
Enrollment change, Combination therapy: SCH708980 With and Without AmBisome for Visceral Leishmaniasis (clinicaltrials.gov) - Aug 25, 2013
P1/2, N=0, Withdrawn, Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Not yet recruiting --> Withdrawn N=90 --> 0
- Enrollment open: Rapid Diagnostic Tests and Clinical/Laboratory Predictors of Tropical Diseases In Patients With Persistent Fever in Cambodia, Nepal, Democratic Republic of the Congo and Sudan (NIDIAG-Fever) (clinicaltrials.gov) - Jan 21, 2013
P=N/A, N=2170, Recruiting, Sponsor: University Hospital, Geneva
N=90 --> 0 Not yet recruiting --> Recruiting
- amphotericin b liposome / Generic mfg.
Enrollment change: LVBrasil: Efficacy and Safety Study of Drugs for Treatment of Visceral Leishmaniasis in Brazil (clinicaltrials.gov) - Jan 13, 2013
P4, N=423, Recruiting, Sponsor: University of Brasilia
Not yet recruiting --> Recruiting N=660 --> 423
- Trial completion: An Effectiveness Study of Paromomycin IM Injection (PMIM) for the Treatment of Visceral Leishmaniasis (VL) in Bangladesh (clinicaltrials.gov) - Aug 9, 2012
P=N/A, N=120, Completed, Sponsor: PATH
N=660 --> 423 Active, not recruiting --> Completed
- | Enrollment change: Replacement of Insecticides to Control Visceral Leishmaniasis (VL) (clinicaltrials.gov) - Jul 30, 2012
P3, N=3600, Recruiting, Sponsor: International Centre for Diarrhoeal Disease Research, Bangladesh
Active, not recruiting --> Completed N=18000 --> 3600
- || New P3 trial: Replacement of Insecticides to Control Visceral Leishmaniasis (VL) (clinicaltrials.gov) - Jul 17, 2012
P3, N=3600, Recruiting, Sponsor: International Centre for Diarrhoeal Disease Research, Bangladesh
- New P2 trial: Safety and Efficacy of Oral Miltefosine in Patients With Post Kala Azar Dermal Leishmaniasis (PKDL) (clinicaltrials.gov) - Jul 8, 2012
P2, N=37, Completed, Sponsor: AB Foundation
- Enrollment open: Bihar Evaluation of Social Franchising and Telemedicine (clinicaltrials.gov) - Oct 13, 2011
P=N/A, N=106380, Enrolling by invitation, Sponsor: Duke University
N=18000 --> 3600 Not yet recruiting --> Enrolling by invitation
- amphotericin b liposome / Generic mfg.
New P1/2 trial, Combination therapy: SCH708980 With and Without AmBisome for Visceral Leishmaniasis (clinicaltrials.gov) - Sep 18, 2011
P1/2, N=0, Withdrawn, Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)